Literature DB >> 17470698

Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice.

Ilze Bot1, Saskia C A de Jager, Alma Zernecke, Ken A Lindstedt, Theo J C van Berkel, Christian Weber, Erik A L Biessen.   

Abstract

BACKGROUND: Mast cells are major effector cells in allergy and host defense responses. Their increased number and state of activation in perivascular tissue during atherosclerosis may point to a role in cardiovascular disorders. In the present study, we investigated the contribution of perivascular mast cells to atherogenesis and plaque stability in apolipoprotein E-deficient mice. METHODS AND
RESULTS: We show here that episodes of systemic mast cell activation during plaque progression in mice leads to robust plaque expansion. Targeted activation of perivascular mast cells in advanced plaques sharply increases the incidence of intraplaque hemorrhage, macrophage apoptosis, vascular leakage, and CXCR2/VLA-4-mediated recruitment of leukocytes to the plaque. Importantly, treatment with the mast cell stabilizer cromolyn does prevent all the adverse phenomena elicited by mast cell activation.
CONCLUSIONS: This is the first study to demonstrate that mast cells play a crucial role in plaque progression and destabilization in vivo. We propose that mast cell stabilization could be a new therapeutic approach to the prevention of acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470698     DOI: 10.1161/CIRCULATIONAHA.106.660472

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  87 in total

Review 1.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

2.  Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.

Authors:  Fei Wang; Yasuo Okamoto; Isao Inoki; Kazuaki Yoshioka; Wa Du; Xun Qi; Noriko Takuwa; Koichi Gonda; Yasuhiko Yamamoto; Ryunosuke Ohkawa; Takumi Nishiuchi; Naotoshi Sugimoto; Yutaka Yatomi; Kunitoshi Mitsumori; Masahide Asano; Makoto Kinoshita; Yoh Takuwa
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

Review 3.  Myeloid cells in atherosclerosis: initiators and decision shapers.

Authors:  Oliver Soehnlein; Christian Weber
Journal:  Semin Immunopathol       Date:  2009-02-24       Impact factor: 9.623

Review 4.  Mast cells in atherogenesis: actions and reactions.

Authors:  Petri T Kovanen
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 5.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

6.  Mast cell function and death in Trypanosoma cruzi infection.

Authors:  Marcelo Meuser-Batista; José Raimundo Corrêa; Vinícius Frias Carvalho; Constança Felícia De Paoli de Carvalho Britto; Otacilio da Cruz Moreira; Marcos Meuser Batista; Maurílio José Soares; Francisco Alves Farias Filho; Patrícia Machado R E Silva; Joseli Lannes-Vieira; Robson Coutinho Silva; Andrea Henriques-Pons
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

7.  Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases.

Authors:  Michael A Shi; Guo-Ping Shi
Journal:  Sci Signal       Date:  2010-11-02       Impact factor: 8.192

8.  Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice.

Authors:  Tatsuya Oka; Janet Kalesnikoff; Philipp Starkl; Mindy Tsai; Stephen J Galli
Journal:  Lab Invest       Date:  2012-08-20       Impact factor: 5.662

9.  CXCR4 blockade induces atherosclerosis by affecting neutrophil function.

Authors:  Ilze Bot; Isabelle T M N Daissormont; Alma Zernecke; Gijs H M van Puijvelde; Birgit Kramp; Saskia C A de Jager; Judith C Sluimer; Marco Manca; Veronica Hérias; Marijke M Westra; Martine Bot; Peter J van Santbrink; Theo J C van Berkel; Lishan Su; Mona Skjelland; Lars Gullestad; Johan Kuiper; Bente Halvorsen; Paul Aukrust; Rory R Koenen; Christian Weber; Erik A L Biessen
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

Review 10.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.